Lauren E. Howard - Publications, H-index & Citations

Lauren E. Howard

Department of Medicine

34H指数

469论文数

4.2K被引数

收录论文 149

发表时间

Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer 转移性雄激素通路调节剂敏感(APMS)前列腺癌患者对雄激素受体通路抑制剂表现出超常反应和耐药性的临床及基因组决定因素

Prostate Cancer and Prostatic Diseases

IF5.8

2026-08-05

OAAI

Jane McKenzie; Lauren Howard; Joseph J. Park; Bilal Ashraf; Tara Seibert; Kallie White; Sundhar Ramalingam; Jeffrey W. Shevach; Michael R. Harrison; Christopher Hoimes; Matthew Labriola; Jordan Infield; Dillon Cockrell; Hannah D. McManus; Daniel J. George; Andrew J. Armstrong

Genetic ancestry–concordant ceramide metabolism and response to androgen receptor pathway inhibition in metastatic castration-resistant prostate cancer 遗传血统一致性与转移性去势抵抗性前列腺癌中鞘脂代谢及雄激素受体通路抑制反应

Cancer

IF5.1

2026-05-26

OAAI

Sean A. Piwarski PhD; Lauren E. Howard MS; Morgan A. Paul MS; Nick Bachelder MS; Bonnie LaCroix BS; Angela Clayton RT(R)(M), CCPR; Donna Allen BSN; Julie Kephart PhD; Andrew J. Armstrong MD, ScM; Steven R. Patierno PhD; Daniel J. George MD; Terry Hyslop PhD; Jennifer A. Freedman PhD

Monitoring treatment response using an ultra-sensitive ctDNA assay in advanced esophagogastric cancer patients 使用超敏ctDNA检测试剂盒监测晚期食道胃腺癌患者的治疗效果

Scientific Reports

IF3.9

2026-03-23

OAAI

Andrew B. Nixon; Fábio C. P. Navarro; Katherine I. Zhou; Charles W. Abbott; Lee McDaniel; Neeraja Ravi; Lauren E. Howard; J. Christopher Brady; Yingmiao Liu; Jingquan Jia; Donna Niedzwiecki; John H. Strickler; Sean M. Boyle; Richard O. Chen; Hope Uronis

Outcomes for Patients With SPOP Mutated Castration-Resistant Prostate Cancer (CRPC) Treated With an Androgen Receptor Pathway Inhibitor (ARPI)携带SPOP突变去势抵抗性前列腺癌(CRPC)患者接受雄激素受体通路抑制剂(ARPI)治疗后的结局

Clinical Genitourinary Cancer

IF2.7

2026-02-01

PREAI

Park, Joseph J.; Howard, Lauren E.; Fragkogianni, Stamatina; George, Daniel J.; Armstrong, Andrew J.

Prevalence of Gender Identity and Incongruence in Adolescent Patients Presenting With Positive Behavioral Health Screens to a Pediatric Emergency Department 青少年患者中性别认同与不一致现象的流行情况：来自儿科急诊科具有积极行为健康筛查结果的研究

Pediatric Emergency Care

IF1.2

2026-02-01

PREAI

Waddell, Ryan; Spray, Beverly; Crawley, Lee; Williams, Jason; De Campos, Samuel Bornia; Howard, Lauren E.; Spiro, David M.

Multimodality Imaging in Evaluating and Guiding Percutaneous Left Atrial Appendage Occlusion 经皮左心耳封堵术的评估与引导中的多模态影像学

Journal of the American Society of Echocardiography

IF6

2025-07-25

PREAI

Renuka Jain; Priscilla Wessly; Muhamed Saric; Karl Richardson; Enrique Garcia-Sayan; Karima Addetia; Lauren Howard; Thomas Finn; Nishath Quader

Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence 前列腺癌中与遗传谱系一致的RNA剪接涉及癌基因并与复发相关

NPJ PRECISION ONCOLOGY

IF8

2025-01-29

OAAI

Al Abo, Muthana; Foo, Wen-Chi; Howard, Lauren E.; Mcgue, Shannon; Lacroix, Bonnie; Kephart, Julie; Clayton, Angela; Thornburg, Blair; Anand, Monika; Rothberg, Michael B.; Mccall, Shannon J.; Huang, Jiaoti; Esther, Thomas A.; Moul, Judd W.; Ferrandino, Michael N.; Polascik, Thomas J.; Robertson, Cary N.; Inman, Brant A.; Armstrong, Andrew J.; Hyslop, Terry; George, Daniel J.; Patierno, Steven R.; Freedman, Jennifer A.

Alternate definitions of adverse pathology to predict a very high risk of metastasis in men with intermediate- and low-risk prostate cancer 预测中、低风险前列腺癌男性转移风险极高的不良病理的替代定义

CANCER

IF5.1

2025-01-02

PREAI

Castaneda, Peris; Kuhlmann, Paige K.; Ithisuphalap, Jaruda; Howard, Lauren E.; Klaassen, Zachary; Rivera, Lourdes Guerrios; Amling, Christopher L.; Aronson, William J.; Cooperberg, Matthew R.; Kane, Christopher J.; Terris, Martha K.; Freedland, Stephen J.

Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2024-10-14

PREAI

Liu, Yingmiao; Li, Jiatong; Lyu, Jing; Howard, Lauren E.; Sibley, Alexander B.; Starr, Mark D.; Brady, John C.; Arrowood, Christy; Kohn, Elise C.; Ivy, S. Percy; Hurwitz, Herbert I.; Abbruzzese, James L.; Owzar, Kouros; Nixon, Andrew B.

Primary Care Use and 90-Day Mortality Among Older Adults Undergoing Cancer Surgery

JAMA SURGERY

IF14.9

2024-10-01

PREAI

Kazaure, Hadiza S.; Neely, N. Ben; Howard, Lauren E.; Hyslop, Terry; Shahsahebi, Mohammad; Zullig, Leah L.; Oeffinger, Kevin C.

Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2024-08-12

PREAI

Deivasigamani, Sriram; Adams, Eric S.; Stock, Shannon; Kotamarti, Srinath; Seguier, Denis; Taha, Tarek; Howard, Lauren E.; Aminsharifi, Alireza; Jibara, Ghalib; Amling, Christopher L.; Aronson, William J.; Cooperberg, Matthew R.; Kane, Christopher J.; Terris, Martha K.; Klaassen, Zachary; Guerrios-Rivera, Lourdes; Freedland, Stephen J.; Polascik, Thomas J.

Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial 在根治性前列腺切除术后前列腺特异性抗原复发性前列腺癌中应用阿帕卢他胺、挽救性放疗和多西他赛强化挽救治疗：STARTAR II期临床试验

European Urology Oncology

IF9.3

2024-07-01

PREAI

Tian Zhang; Lauren Howard; Bridget F. Koontz; Scott T. Tagawa; Himanshu Nagar; Rhonda L. Bitting; Bart A. Frizzell; Luke Nordquist; Julia Rasmussen; Colleen Riggan; Marco Reyes; Catrin Davies; Steven R. Gray; Carly R. Newman; Escarleth Fernandez; Sundhar Ramalingam; Michael R. Harrison; Daniel J. George; Yuan Wu; Andrew J. Armstrong

Treatment guideline concordance for patients with metastatic hormone-sensitive prostate cancer (mHSPC) in the United States in IRONMAN, the International Registry for Men with Advanced Prostate Cancer

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

McManus, Hannah Dzimitrowicz; Howard, Lauren; Crowell, Kerri-Anne; Hyslop, Terry; Vinson, Jake; Rathkopf, Dana E.; Kantoff, Philip; Mucci, Lorelei A.; George, Daniel; Stopsack, Konrad

Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer 短期醋酸阿比曲酮和LHRH激动剂治疗不良中危和高危前列腺癌的5年更新结果

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2024-02-22

PREAI

Fecteau, Ryan E.; Koontz, Bridget F.; Hoffman, Karen E.; Halabi, Susan; Howard, Lauren E.; Anand, Monika; George, Daniel J.; Zhang, Tian; Berry, William R.; Lee, W. Robert; Harrison, Michael R.; Corn, Paul G.; Armstrong, Andrew J.

Differential alternative RNA splicing and transcription events between Black and White prostate cancer patients involve genes promoting cancer aggressiveness and associate with patient survival

CANCER RESEARCH

IF16.6

2023-06-02

PREAI

Al Abo, Muthana; Foo, Wen-Chi; Howard, Lauren; Anand, Monika; George, Daniel J.; Patierno, Steven R.; Freedman, Jennifer A.

Doppler flow velocity profile of the left anterior descending in a patient with hypertrophic cardiomyopathy and markedly elevated left ventricular end-diastolic pressure: a novel observation

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING

IF6.6

2023-04-19

PREAI

Peters, Matthew; Galazka, Patrycja; Howard, Lauren; Tajik, A. Jamil

Race- and ancestry-related metabolites and SNPs associated with response to secondary hormonal therapy in metastatic castration-resistant prostate cancer

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Piwarski, Sean Alan; Allen, Tyler; LaCroix, Bonnie; Howard, Lauren; Paul, Morgan; Bachelder, Nick; Sibley, Alex; Patierno, Steve; Hyslop, Terry; Owzar, Kouros; George, Daniel; Freedman, Jennifer

Identification of Patients With Metastatic Prostate Cancer With Natural Language Processing and Machine Learning

JCO CLINICAL CANCER INFORMATICS

IF2.8

2022-12-01

PREAI

Yang, Ruixin; Zhu, Di; Howard, Lauren E.; De Hoedt, Amanda; Williams, Stephen B.; Freedland, Stephen J.; Klaassen, Zachary

Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2022-09-01

PREAI

Klaassen, Zachary; Howard, Lauren; Wallis, Christopher J. D.; Janes, Jessica L.; De Hoedt, Amanda; Aronson, William J.; Polascik, Thomas J.; Amling, Christopher J.; Kane, Christopher J.; Cooperberg, Matthew R.; Terris, Martha K.; Wu, Yuan; Freedland, Stephen J.

Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2022-06-06

PREAI

Chen, Michelle S.; Howard, Lauren E.; Stock, Shannon; Dolgner, Anna; Freedland, Stephen J.; Aronson, William; Terris, Martha; Klaassen, Zachary; Kane, Christopher; Amling, Christopher; Cooperberg, Matthew; Daskivich, Timothy J.

研究方向